Thus, a subset of fibroblasts (CD34−PDPN+THY1+), which produce high levels of MCP-1 and IL-6, is particularly prevalent in the inflamed synovium of RA patients with a poor response to currently approved anti-rheumatic drugs [1,13,14,15]. The gene discussed is IL6; the disease is rheumatoid arthritis.